Work

The experience of anti-b-cell therapy with rituximab in children with chronic inflammatory demyelinating polyradiculoneuropathy with a description of the clinical case

Year: 2024

Type: article

Abstract: Chronic inflammatory demyelinating polyneuropathy, which occurs in childhood, is usually treatable with the use of standard immunosuppressive drugs. Patients with refractory course may have disabling complications and need biological therapy. The article provides information about the disease and a description of a case refractory to standard therapy with a good response to biological therapy with rituximab.

Source: Russian Journal for Personalized Medicine

DOI: 10.18705/2782-3806-2024-4-4-319-328

Authors: N. А. Lyubimova, T. M. Pervunina, K. A. Seel, M. M. Kostik

Institutions: Federal Almazov North-West Medical Research Centre, Saint Petersburg State Pediatric Medical University

Language: English

Topic: Peripheral Neuropathies and Disorders

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4402537696

FWCI:

Cites: 21

Cited by:

Related to: 10